Projects

RNDr. Silvia Borecká, PhD.

International

Current
  • European Network for Sigma-1 Receptor as a Therapeutic Opportunity
    Program: COST
    Duration: 25. 10. 2024 – 24. 10. 2028

National

Current
  • Genetic causes of rare inherited metabolic diseases with emphasis on functional studies of novel variants
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • Mitochondrial disease in heart failure
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • Mutations associated with Wolfram syndrome: alternative signaling pathways for calcium and mitochondrial physiology
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
Finished
  • Identification of novel genetic variants in syndromic hearing loss by whole exome sequencing
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
  • Genetics of rare forms of diabetes with focus on functional characterization of new variants
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Identification of etiology in sporadic forms of hereditary hearing loss by whole exome sequencing
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Cell-in-cell phenomena as microevolutionary processes in cancer progression: a role for hypoxia-induced carbonic anhydrase IX
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Comprehensive innovative diagnostics and personalized treatment of diabetes mellitus in children
    Program: Other projects
    Duration: 1. 10. 2019 – 31. 3. 2022
Employees